← Leaderboards
Mark G Klang
Sloan-Kettering Inst Can Research
$864,536
Attributed
$864,536
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $203.9K · FY2008–13$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$864,536 · 1
By mechanism
P30$864,536 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Elisa De Stanchina$4,011,743
- Raymond J Muller$2,385,467
- Jason S Lewis$26,024,327
- Ting Bao$7,173,596
- Michelle S Bradbury$7,087,200
Others in their field
Top investigators on “Oral”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$236,409,338
- Judith S. Currier · University Of California Los Angeles$134,347,732
- Constance Ann Benson · University Of California, San Diego$123,741,444
- Wafaa M. El-Sadr · Columbia University Health Sciences$92,413,650
- Myron S Cohen · Family Health International$91,263,426
- Robert A Wood · Johns Hopkins University$57,641,510
Research focus
OralPharmaceutical PreparationsPharmacy FacilityPlacebo Controlled StudyPreparationSmall MoleculeServicesCyclic GmpDetectorDevicesAntibodiesVaccinesEquipmentEvaluationExcipientsValidationFluorescenceSterilityGrowthCapsule (Pharmacologic)InjectableInjection Of Therapeutic AgentClinical TrialsLife
Grant awards (6)
RESEARCH PHARMACY$203,868
P30 · FY2013 · CA · contact PI
RESEARCH PHARMACY$92,614
P30 · FY2012 · CA · contact PI
RESEARCH PHARMACY$184,418
P30 · FY2011 · CA · contact PI
RESEARCH PHARMACY$190,335
P30 · FY2010 · CA · contact PI
RESEARCH PHARMACY$96,730
P30 · FY2009 · CA · contact PI
RESEARCH PHARMACY$96,571
P30 · FY2008 · CA · contact PI